EW

Ester Weijers

CEO

NTrans Technologies

NTrans Technologies Pipeline

DrugIndicationPhase
Platform Application: CAR-T EnhancementCancer (Immuno-oncology)Pre-clinical
Platform Application: CRISPR/Cas9 DeliveryGenetic Diseases (Research & Therapeutic)Pre-clinical
Platform Application: Base Editor DeliveryGenetic DiseasesPre-clinical
Platform Application: Prime Editor DeliveryGenetic DiseasesPre-clinical